[HTML][HTML] Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome

J Fang, Q Wu, F Ye, C Cai, L Xu, Y Gu, Q Wang… - Frontiers in …, 2021 - frontiersin.org
Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …

[HTML][HTML] Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome

J Fang, Q Wu, F Ye, C Cai, L Xu, Y Gu, Q Wang… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome

J Fang, Q Wu, F Ye, C Cai, L Xu, Y Gu… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome.

J Fang, Q Wu, F Ye, C Cai, L Xu, Y Gu, Q Wang… - Frontiers in …, 2021 - europepmc.org
Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome.

J Fang, Q Wu, F Ye, C Cai, L Xu, Y Gu, Q Wang… - Frontiers in …, 2021 - europepmc.org
Despite that several therapeutic agents have exhibited promising prevention or treatment on
Coronavirus disease-2019 (COVID-19), there is no specific drug discovered for this …